A Crossover, Multicentre, Randomised Trial Comparing the Effect on the Control of Blood Glucose Concentration of Insulin Glargine and Insulin Detemir, Combined With Insulin Glulisine, Used as a Bolus, in Type 1 Diabetic Patients.
Phase of Trial: Phase III
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Insulin detemir; Insulin glargine; Insulin glulisine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms VARIABILITE
- Sponsors Sanofi
- 07 Jul 2009 Additional lead trial investigator (Sebille M) identified as reported by ClinicalTrials.gov.
- 05 Oct 2008 Actual end date Sep 2008 added as reported by CT.gov
- 05 Oct 2008 number of patients changed from 86 to 88 as reported by CT.gov